June 25, 2017 5:53 AM ET

Healthcare Equipment and Supplies

Company Overview of Daktari Diagnostics, Inc.

Company Overview

Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

85 Bolton Street

Cambridge, MA 02140

United States

Founded in 2008





Key Executives for Daktari Diagnostics, Inc.

Chief Executive Officer, President and Director
Vice President of Finance
Vice President of Product Design and Development
Vice President of Quality & Regulatory
Vice President of Assay & R&D
Compensation as of Fiscal Year 2016.

Daktari Diagnostics, Inc. Key Developments

Daktari Diagnostics and SystemOne Enters into Development and License Agreement

Daktari Diagnostics and SystemOne announced the companies have entered into a development and license agreement to integrate Daktari's technology platform with SystemOne's connectivity platform, Aspect. This collaboration aims to improve the value of diagnostics by linking clinically relevant test results and operational data from Daktari's point-of-care (POC) diagnostics to Daktari's device users via secure mobile networks and simple-to-use interfaces, including SMS, email, and an online dashboard. As many customers in Daktari's target markets are lacking access to streamlined electronic medical records, SystemOne's Aspect enables healthcare practitioners to provide real-time, complete disease surveillance and monitoring capabilities and provide assistance to global health officials evaluating the impact of their efforts on public health. The World Health Organization (WHO) has identified the development and implementation of common standards for POC diagnostic connectivity platforms, especially those for infectious diseases, for local health care centers in lower- and middle-income countries (LMICs) as a global health priority. In LMICs where electronic medical record systems are still evolving, there remains a need to align POC diagnostics with health information technology in a standardized way in order to provide more effective and comprehensive patient management. A prototype version of the Aspect connectivity system is expected in the first quarter of 2017. Daktari's Hepatitis C Virus Core Antigen (HCV-cAg) test and HIV Viral Load test will be the first in a series of immunoassay products in development to support this collaboration.

Daktari Diagnostics Appoints Donald B. Hawthorne as President & Chief Executive Officer and Member of the Board of Directors

Daktari Diagnostics announced the appointment of Donald B. Hawthorne as President & Chief Executive Officer (CEO), and member of the Board of Directors. Mr. Hawthorne brings over 30 years of life sciences industry experience, most recently as President & CEO of AdvanDx.

Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus

Daktari Diagnostics announced a collaboration with Merck, known as MSD outside the United States and Canada, to develop Daktari's rapid hepatitis C virus (HCV) screening test. The deal, worth up to $8.5 million over the next 3.5 years, will support an accelerated development timeline for the clinical validation and regulatory approval of Daktari's HCV test. The Daktari technology forms the basis for a point-of-care instrument that can detect low levels of virus directly in a single drop of blood in approximately 30 minutes, making on-the-spot HCV treatment decisions possible. The Daktari test is based on high-sensitivity measurement of the HCV core antigen, which is used in Europe and Japan for the diagnosis of chronic hepatitis C infection, but has never been available as a point-of-care diagnostic. The Daktari System includes an embedded connectivity platform, Daktari InSight, which provides real-time data management through mobile network connectivity and a web-based dashboard, allowing rapid monitoring of test results. The Daktari System has the potential to transform public health screening programs and be made available at retail clinics, pharmacies, and doctor's offices.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Daktari Diagnostics, Inc., please visit www.daktaridx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.